Pharmaceutical Residual Contaminants & Impurities

Impurities can be generated or contaminate pharmaceutical product at many points during the development, manufacture and distribution process. They may include synthetic, degradation or elemental impurities, and substances extracted or leached during production and storage from container closure systems.

Our global network of experts can accelerate the identification and mitigation of issues associated with your key starting materials or excipients, potential impacts arising from your manufacturing and cleaning processes or changes in storage materials and transport conditions. This ensures your products remain safe right throughout the supply chain, enabling you to comply with all your regulatory and patient safety commitments.